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Abstract
Introduction: Due to the risks of pregnancy outcomes in relation to IPV and the increased rates
of IPV as a result of COVID-19 precautions, health care screening for IPV in the prenatal process is
even more imperative for preventing negative healthcare outcomes for both the pregnant patient
and children.
Background: Intimate partner violence (IPV) is a significant public health issue that puts both
baby and pregnant patients at risk for severe negative healthcare outcomes. Healthcare screening is
a tool to find a condition or to learn more about a patient before symptoms become severe.
Methods: Screening for IPV and the effects of COVID-19 on rates of IPV were reviewed
individually. A semi-structured interview was developed to learn more about how obstetricians
approach screening of pregnant patients. Twenty-three physicians were emailed for informational
interviews.
Results: Three (18.8%) physicians agreed to be interviewed. Three main themes were identified
during the interviews. There was no formal IPV training, the confidentiality necessary to screen a
patient for IPV has been compromised since many appointments with pregnant patients have
moved from in-person to virtual, and third, the lack of childcare in clinics is a limiting factor for the
possibility for pregnant patients to attend regular appointments because of the Covid-19 social
distancing restrictions and guidelines.
Conclusion: The biggest barriers found during this research were not training procedures
themselves but the uncontrollable variables that have been further complicated by the pandemic.
Future research needs to go into the screening practices and capabilities in the virtual arena now
that telehealthcare will likely be available beyond the Covid-19 pandemic.
Introduction
The World Health Organization labeled COVID-19 a global pandemic on March
11th, 2020. Since then, there have been countless stay-at-home orders across the United
States of America, which has, in turn, played a large part in a surge of Intimate partner
violence (IPV) cases due to increased isolation. (Kofman, 2020). There is substantial
research connecting the presence of IPV during pregnancy with adverse pregnancy
outcomes like preterm birth (PTB) and low birth weight (LBW) (O’Reilly, 2010). Both
instances of IPV and COVID-19 are disproportionately prevalent amongst BIPOC
(Black, Indigenous, and People of Color) communities (Stockman, 2015 and Valenzuela,
2020). Due to the risks of pregnancy outcomes in relation to IPV and the increased rates
A Hidden Crisis During COVID-19
of IPV as a result of COVID-19 precautions, health care screening for IPV in the prenatal
process is even more imperative for preventing negative healthcare outcomes for both
the pregnant patient and children. Protocols for screening procedures with the intent to
center the safety of potential patients experiencing IPV set long before the start of the
global pandemic are now complicated with barriers introduced by COVID-19 thus
placing pregnant patients, and especially those identifying as BIPOC, in higher states of
risk for negative health outcomes. The purpose of this study is to learn if physicians have
had specialized training regarding IPV screening, what screening procedures physicians
use during appointments with pregnant patients, how COVID-19 has altered screening
practices, and to explore the implications for BIPOC patients.
Background
Intimate partner violence (IPV) is a significant public health issue that puts both
baby and pregnant patients at risk for severe negative healthcare outcomes. The Center
for Disease Control (2020) defines IPV as “physical violence, sexual violence, stalking,
or psychological harm by a current or former partner or spouse.” Exposure to IPV has
been shown to increase the risk of spontaneous abortion, fetal loss, PTB, LBW, and
neonatal death (Alhusen, 2015). Approximately 42.4 million (35.6%) women in the
United States have experienced IPV within their lifetime. Intimate partner violence  has
had a 20% increase globally during the COVID-19 pandemic (Miller, n.d.). The National
Intimate Partner and Sexual Violence Survey indicates the prevalence of IPV amongst
non-Hispanic Black and Native American/Alaskan Native women is significantly higher
(43.7% and 46% respectively) compared to non-Hispanic white women (34.6%)
(Stockman, 2015).
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Healthcare screening is a tool to find a condition or to learn more about a patient
before symptoms become severe. Regular health care screening is a part of yearly
check-ups, for example. Some familiar questions that a primary care provider has most
likely asked patients could be: Do you have a family history for diabetes? Do you use
tobacco? How often do you drink alcohol? How many sexual partners do you have? Etc.
Most healthcare providers should ask similar questions specifically geared toward
assessing the possibility of IPV in a pregnant patient. 
Literature Review
In 1992 the American Medical Association (AMA) recommended that all women
who access primary care (and some secondary care facilities) get screened for IPV
(American Medical Association Diagnostic and Treatment Guidelines on Domestic
Violence, 1992). However, despite recommendations, the approach to screening for IPV
during pregnancy is not universal. The CDC in 2004 concluded that “the extent to which
US clinicians incorporate screening for IPV into their practices is relatively unknown”
(Bailey, 2010). More recently in 2015, despite the recommendations of the United States
Preventive Services Task Force (USPSTF), studies have shown that only 1.5%-12% of
pregnant patients get screened for IPV despite the fact that 96% receive prenatal care
(Intimate Partner Violence Screening, 2015). Screening is a tool to identify IPV in a
pregnant patient which allows providers a unique ability to detect IPV early due to
elongated relationships with the patient throughout their pregnancy. If IPV is detected
early during screening it may even help prevent adverse effects on maternal and
pregnancy outcomes.  In a systematic literature review, Bailey (2010) found at that time
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numerous organizations and healthcare providers had recommended a universal
screening procedure, but there did not appear to be a universal practice in place.
The 2017 Women's Health Survey conducted by the Kaiser Family Foundation
(KFF) shows that in 2017 only 27% of women reported they were screened for IPV with
a medical provider and women who were low-income, on Medicaid, and/or identified as
Black or Latina were the most likely to be screened (Gomez et al., 2018). Researchers
went on to specify that Latina women and women covered by Medicaid were
significantly more likely to seek care from community health centers or clinics and
argued that clinics are essential to the care of women of color. Community health
centers that frequently serve marginalized populations would know the barriers their
patients are predisposed to thus offering a possible reason why women on Medicaid
and/or Black and Latina women were more likely to be screened.
The U.S. Preventive Services Task Force (USPSTF) reviewed a number of
screening tools and came up with a list of six they recommended for their sensitivity and
specificity: HITS (Hurt, Insult, Threaten, Scream), OVAT (Ongoing Violence
Assessment Tool), STaT (Slapped, Things, and Threaten), HARK (Humiliation, Afraid,
Rape, Kick), CTQ-SF (Modified Childhood Trauma Questionnaire– Short Form), WAST
(Women Abuse Screen Tool) (Agency for Healthcare Research and Quality [AHRQ],
2015). Four of the six screening tools are discussed in a PDF document from the CDC in
a collection of almost one hundred other screening tools designed by variations of
doctors, non-profit organizations, universities, clinics, and hospitals (Center for Disease
Control [CDC], 2007). The STaT screening tool must be purchased from an outside
organization but is referenced. Each one uses a scoring process to determine the level of
risk. Providers without training or extensive knowledge may have a difficult time
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understanding the differences, deciding which one to use, and learning how to
implement with the safety of a patient in mind. The CDC’s endorsement of so many
screening tools rather than a set of universally recommended standards runs the risk of
confusing providers and causing a lowered rate of screening or, more dangerously,
improper screening that could put the patient in further danger.
The Agency for Healthcare Research and Quality (AHRQ) recommends
numerous screenings for IPV at “periodic intervals, including obstetric care at the first
prenatal visit, at least once per trimester, and at the postpartum checkup” which is in
accordance with other official organizations such as the United States Department of
Health and Human Services (HHS) and the Institute of Human Medicine (IOM)
(AHRQ, 2015). Authors Ramaswamy, Ranji, and Salganicoff (2019) also discuss IPV
screening tools in their recent study published by the Kaiser Family Foundation (KFF)
in which they agree with the AHRQ’s recommendations for screening intervals and
further explore barriers to the screening process. They argue that the main barriers
providers face with regards to IPV screening is the presence of a partner, lack of time to
build a relationship that would encourage patients to disclose, patients’ concerns about
mandatory reporting laws, and lack of adequate knowledge about the issue of IPV and
screening procedures itself (possibly explained by the number of screening tools
available to them rather than a clear set of universal guidelines).
The COVID-19 pandemic forced national stay-at-home mandates across the
United States which have forced victims of IPV to be isolated with their abusers.
Intimate partner violence hotlines expected to see states increase the demand for their
services. However, many organizations have seen major declines in calls which is an
alarming observation (Evans, 2020). This indicates that people do not feel safe enough
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to call IPV hotlines. Organizations such as the World Health Organization (WHO) have
already conducted extensive research and published articles regarding the intersection
of COVID-19 with instances of IPV. The WHO examined variables that exacerbated the
risks for violence against women and found that increased stress (mental, physical, and
financial) accompanied by the stay-at-home orders accounts for the greatest increase in
risk (World Health Organization [WHO], 2020). Isolation and social distancing have left
many in the United States unable to see friends and family who, for many women
experiencing IPV, may be the only source of support and safety they have. Women may
also have a difficult time connecting to community centers, hotlines, and healthcare due
not only to the constant presence of abusers but also lowered services as organizations
attempt to protect their employees. Abusers have traditionally exhibited control by
taking away access to necessary items and the WHO stated that “perpetrators may also
restrict access to necessary items such as soap and hand sanitizer… exert control by
spreading misinformation about the disease and stigmatize partners” (WHO, 2020, p. 1)
A representative from the National Domestic Violence Hotline (NDVH) shared
anonymous stories about calls since the start of the pandemic that corroborate the
WHO’s research with a journalist from The Guardian (Fielding, 2020). According to the
representative, 951 callers between March 10th and March 24th, 2020 mentioned
COVID-19. Fielding wrote of the calls,
One caller to a domestic violence hotline reported that her husband threatened to
throw her out into the street if she coughed. Another reported they had been
strangled by their partner, but feared going to the hospital because of the threat
of coronavirus. An immunocompromised man from Pennsylvania called in after
his emotionally abusive girlfriend began hiding cleaning supplies and hand
sanitizer from him.
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The WHO also offered recommendations for policymakers, health care providers,
humanitarian organizations, community members, and women experiencing violence in
the wake of new COVID-19 barriers, but it is on individual systems and people to take on
the work (WHO, 2020).
Methods
Terms and descriptions have been carefully considered in the planning and
execution of this thesis. ‘Intimate partner violence’ is used instead of its commonly used
counterpart ‘interpersonal violence’ as the latter refers to violence between individuals
whereas the former touches on an intimate relationship putting potential strain on a
pregnancy and the screening of IPV. Domestic violence was not used as this term is
specific to relationships in which all parties live in the same household. Patients are
referred to as ‘pregnant patients’ in the context of this research while terminology in the
literature review reflects the terminology used in the original source. This decision was
made to encompass the wide spectrum of people who can become pregnant and avoid
assuming gender. The acronym ‘BIPOC’ is used as opposed to the common ‘POC’ it
highlights the specific experiences that Black and Indigenous peoples have experienced
over the course of history.
This research paper started through a preliminary literature review. The
intersection of COVID-19 and IPV was well-researched prior to the beginning of this
project, though its conjoined effects on screening were not discussed. Screening for IPV
and the effects of COVID-19 on rates of IPV were reviewed individually, the former
reviewed first. This included researching types of screening procedures, implementation
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of screening procedures, barriers to screening procedures, and the similarities and
differences in cases of IPV before and during the pandemic.
After establishing the purpose of this research through a literature review, a
semi-structured interview was developed  to learn more about how OB/GYNs approach
screening pregnant patients. The project proposal was reviewed by the Portland State
University IRB and granted exemption approval. Twenty-three physicians were emailed
for informational interviews from a large healthcare organization. This study only
sought out practicing physicians with medical degrees. The physicians were all sent a
copy of the consent procedure and interview questions. The physicians who were
interviewed were sent a Webex link for a virtual meeting. The interviewees gave their
verbal consent at the start of the interview. The audio and video from the interviews
were recorded via Webex. Additionally, the software recorded a written transcription of
the interviews. The responses were analyzed via content analysis to identify key themes.
After the key themes were extracted from the data the recorded audio, video, and
transcription data were destroyed.
The content analysis consisted of creating a spreadsheet organized based on
interviewee and question number. The interview responses were listed in order and
segments were pulled out. From there specific phrases were identified to hone in on key
themes. Three themes were identified followed by a limited selection of important
points that proved necessary to consider as well.
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Results
Out of the twenty-three physicians contacted, sixteen (69.65%) responded. Of the
sixteen physicians who responded, three (18.8%) physicians provided recommendations
for other potential interviewees. Three (18.8%) physicians who responded to the
recruitment email, agreed to be interviewed. Three main themes were unanimously
identified during all of the interviews. The first being that there was no formal training
in regards to IPV training. All three physicians indicated that they had training for IPV
screening at some point during their training but had no formal training. The second
theme was that the confidentiality necessary to screen a patient for IPV has been largely
compromised since many appointments with pregnant patients have moved from
in-person to virtual due to the social distancing rules put into place. This negatively
impacts IPV disclosure. The last theme was that the lack of childcare in clinics is a
limiting factor for the possibility for pregnant patients to attend regular appointments
because of the Covid-19 social distancing restrictions and guidelines. One of the
interviewees went as far as to say that the issue should be ‘yelled about from rooftops’.
Additionally, a physician indicated a key patient population not included in this study is
the patient population seeking to terminate their pregnancy.
All physicians indicated the use of a standardized script in their practices which
has increased the frequency of the screening capabilities since the start of the Covid-19
pandemic. In regards to if Covid-19 had increased the instances of IPV in their patients,
the responses were mixed. Some spoke to the increased prevalence anecdotally and
others stated that there has not been a broad investigation into if there has been an
increased prevalence of IPV in their patients so the answer is unknown.
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Discussion
A significant barrier to providers’ screening procedures is a lack of formal
training for screening for IPV in pregnant patients for the physicians. The formal
training should consist of guidance on how to navigate the conversation, and how to
counsel and refer patients who have disclosed that they are experiencing IPV (Schrier,
2017). A module that incorporated these two main themes saw a high rating from 90%
of the 260 second-year medical students who utilized it. The lack of formal training can
leave providers ill-equipped and uncomfortable when having a difficult conversation
like this which may offer negative impacts on the rate of conducted screenings.
Due to the nature of the Covid-19 pandemic, many appointments have been
shifted to the virtual realm making it more likely that patient partners are present or
privacy is not guaranteed, something that may happen if a patient must stay home due
to a lack of childcare. This then flags the appointment because the provider was unable
to screen the patient for IPV due to the risk of placing the patient in a dangerous
situation. Lack of privacy also negatively impacts the possibility of disclosure. This is
important because the provider is unable to screen the patient and ensure privacy as
they might otherwise be able to do in a private room in their clinic. The implication is
that patients will not be screened despite a possibility of being IPV positive, ultimately
risking serious negative health outcomes in addition to their growing fetus.
Limited access to childcare was listed as a large impact on patients' ability to
attend meetings with physicians. The social distancing guidelines have closed the
in-house child care services previously available, meaning that patients have to look for
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other childcare arrangements. This could increase travel time and be a limitation to be
able to attend a meeting. One of the interviewees indicated that the lack of childcare
services is a large barrier for, particularly, BIPOC patients. BIPOC patients might have
to work more and work in lower-paying jobs across the board due to systemic racism
and lack of generational wealth.
Conclusion
There is conflicting data on the importance of universal screening procedures.
The physicians interviewed had a consensus that screening is easier now due to
standardized practices, while sources in the literature found that the lack of universal
procedures (despite standardized practices) offers little accountability and limited
guidance. The biggest barriers found from the interviews were not the procedures
themselves, but uncontrollable variables complicating the completion of the screening.
It is the uncontrollable variables that have been further complicated by the pandemic
and the introduction of telehealth medicine. These barriers will be difficult to counteract
as they are unique to the patients and the systems they work within (i.e. access to
childcare, partners who work from home, access to transportation, a clinic’s set up, and
ability to expand care). However, one interviewee pointed out that nurses took on a bit
more in an attempt to complete screening. When a patient was flagged due to an
incomplete screening via a telehealth appointment, a nurse would then conduct a
follow-up phone call. If confidentiality was achieved, screening was conducted. Gomex
et al.  found that utilizing the relationship with a nurse to counteract time constraints in
an appointment has increased the rate of screening. It seems that the relationship
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between the nurse, the physician, and the patient is an important variable that can be
capitalized on for telehealth screening procedures.
A major limitation is that three people were interviewed. Those three people were
all OB/GYN physicians from one practice.  Further research should conduct more
interviews with a wider variety of healthcare professionals and from different practices.
Additionally, all the physicians were a part of the same organization and served a
pregnant patient population that chose not to terminate their pregnancies Further
research should explore that population because their experiences with IPV could be
completely different. Future research needs to go into the screening practices and
capabilities in the virtual arena now that telehealth care will likely be available beyond
the Covid-19 pandemic.
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